Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Trading Update

25 Oct 2012 07:00

RNS Number : 4783P
Imaginatik PLC
25 October 2012
Β 

ο»Ώ

25 October 2012

Imaginatik Plc

("Imaginatik" or the "Company")

Β 

Trading Update

Β 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offeringΒ a range of technology products and consultancy, is pleased to provide a trading update for the six months ended 30 September 2012.

Β 

As announced at the time of the AGM on 14 September, Imaginatik made good progress in the first half of the financial year. As anticipated at the AGM, the Company successfully contracted a further five additional customers in the last few weeks of the period, bringing the total number of new customers in the first half to 17 (H1 2011: 6). Of these, nine were annual contracts (including Air Products and Chemicals Inc. and Chartis Global Services, Inc.), five were pilot projects (including MillerCoors and Merck & Co. Inc.) with the balance being consultancy-led engagements.

Β 

Revenue for the first half is expected to be approximately Β£1.75m, (H1 2011: Β£1.62m) with operating losses, before share-based payments, expected to be approximately Β£0.36m (H1 2011: Β£0.43m). During the period the Company has capitalised development costs amounting to Β£0.12m, (H1 2011: Β£nil).

Β 

One of the annual contracts referred to above was the conversion of a consultancy-led engagement with a major international US based mining company. The company had been a consultancy customer of Imaginatik's since January 2012. This conversion further reinforces Imaginatik's strategy to offer a 'full service' innovation platform combining software with a mixture of strategic and operational consultancy.

Β 

The Company expects to announce its interim results for the six months ended 30 September 2012 towards the end of November.

Β 

Matt Cooper, Executive Chairman of Imaginatik, commented: "We are pleased to see further evidence that our transition to a full service innovation provider is starting to bear fruit, in particular our consulting capabilities continue to differentiate us from our competitors. Trading in the second half has begun well and, with a strong pipeline of opportunities and renewals for the second half, we remain confident of a successful outcome for the year as a whole."

Β 

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

Β 

About Imaginatik

Β 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. Imaginatik's mission is to help these companies build sustainable innovation competencies.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visitΒ www.imaginatik.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPGGUUUUPPGMC
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSFinal Results
11th Jun 20128:00 amRNSProposed Placing
17th Apr 20127:00 amRNSContract Wins
17th Apr 20127:00 amRNSTrading Update
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.